Prothrombin gene G20210→A transition is a risk factor for cerebral venous thrombosis

Stroke

Volumn 29, Issue 9, 1998, Pages 1765-1769

  Reuner, Karl H ^a   Ruf, Andreas ^b   Grau, Armin ^b   Rickmann, Henning ^b   Stolz, Erwin ^b   Jüttler, Eric ^b   Druschky, Karl F ^b   Patscheke, Heinrich ^b  

^a Klinikum Karlsruhe   (Germany)

^b NONE

Author keywords

Coagulation; Hereditary disease; Sinus thrombosis; Thrombophilia

Indexed keywords

ADENINE; DNA; GUANINE; PROTHROMBIN; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; BRAIN VEIN; CEREBROVASCULAR ACCIDENT; CHILD; CONTROLLED STUDY; FEMALE; HETEROZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; RISK FACTOR; TRANSIENT ISCHEMIC ATTACK; VEIN THROMBOSIS; BLOOD CLOTTING; CEREBRAL SINUS THROMBOSIS; GENETICS; GENOTYPE; MIDDLE AGED; POINT MUTATION; PRESCHOOL CHILD; THROMBOPHILIA;

ADOLESCENT; ADULT; AGED; BLOOD COAGULATION; BRAIN ISCHEMIA; CEREBRAL VEINS; CHILD; CHILD, PRESCHOOL; CONTRACEPTIVES, ORAL; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; PROTHROMBIN; RISK FACTORS; SINUS THROMBOSIS, INTRACRANIAL; THROMBOPHILIA;

EID: 0031595694     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.9.1765     Document Type: Article

References (26)

1. Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin. 1992; 10:87-111.
2. Heistinger M, Rumpl E, Illiasch H, Türck H, Kyrle PA, Lechner K, Pabinger I. Cerebral sinus thrombosis in a patient with hereditary protein S deficiency: case report and review of the literature. Ann Hematol. 1992;64:105-109.
3. Cantù C. Barinagarrementeria F. Cerebral venous thrombosis associated with pregnancy and puerperium. Stroke. 1993;24:1880-1884.
4. Brey RL, Coull BM. Cerebral venous thrombosis: role of activated protein C resistance and factor V gene mutation. Stroke. 1996;27: 1719-1720.
5. Deschiens MA, Conard J, Horellou MH, Ameri A, Preter M, Chedru F, Samama MM, Bousser MG. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke. 1996;27:1724-1730.
6. Martinelli I, Rosendaal FR, Vandenbroucke JP, Mannucci PM. Oral contraceptives are a risk factor for cerebral vein thrombosis. Thromb Haemostasis. 1996;76:477-478. Letter.
7. De Bruijn SFTM, Stam J, Koopman MMW, Vandenbroucke JP. Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users who are carriers of hereditary prothrombotic conditions. Br Med J. 1998;316:589-592.
8. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698-3703.
9. Hillarp A, Zöller B, Svensson PJ, Dahlbäck B. The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thromb Haemost. 1997;78: 990-992.
10. Cumming AM, Keeney S, Salden A, Bhavnani M, Shwe KH, Hay CRM. The prothrombin gene G20210A variant: prevalence in a U. K. anticoagulant clinic population. Br J Haematol. 1997;98:353-355.
11. Brown K, Luddington R, Williamson D, Baker P, Baglin T. Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′-untranslated region of the prothrombin gene. Br J Haematol. 1997;98:907-909.
12. Makris M, Preston FE, Beauchamp NJ, Cooper PC, Daly ME, Hampton KK, Bayliss P, Peake IR, Miller GJ. Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thromb Haemostasis. 1997;78:1426-1429.
13. Arruda VR, Annichino-Bizzacchi JM, Goncalves MS, Costa FF. Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease. Thromb Haemostasis. 1997;78:1430-1433.
14. Rosendaal FR, Siscovick DS, Schwartz SM, Psaty BM, Raghunathan TE, Vos HL. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood. 1997;90: 1747-1750.
15. Bentolila S, Ripoll L, Dronet L, Mazoyer E, Woimant F. Thrombophilia due to 20210 G→A prothrombin polymorphism and cerebral ischemia in the young. Stroke. 1997;28:1846-1847. Letter.
16. Martinelli I, Franchi F, Akwan S, Bettini P, Merati G, Mannucci PM. The transition G to A at position 20210 in the 3′-untranslated region of the prothrombin gene is not associated with cerebral ischemia. Blood. 1997; 90:3806. Letter.
17. Reuner KH, Litfin F, Patscheke H. Discrimination between normal wildtype and carriers of coagulation factor V Leiden mutation by the activated protein C resistance test in the presence of factor V deficient plasma. Eur J Clin Chem Clin Biochem. 1997;35:41-45.
18. Martolini JL, Stocker K. Functional protein C assay using protac, a novel protein C activator. Thromb Res. 1986;43:253-259.
19. Wolf M, Boyer-Neumann C, Martolini JL, Amiral J, Meyer D, Larieu MJ. A new functional assay for human protein S using activated factor V as substrate. Thromb Haemostasis. 1989;62:1144-1145.
20. Triplet DA, Brandt JT, Kaczor D, Schaeffer J. Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure. Am J Clin Pathol. 1983;79:678-682.
21. Bloem BR, van Putten MJAM, vd Meer FJM, van Hilten JJ, Bertina RM. Superior sagittal sinus thrombosis in a patient heterozygous for the novel 20210 A allele of the prothrombin gene. Thromb Haemostasis. 1998; 79:235. Letter.
22. Conard J, Brouzes C, Biousse V, Horellou MH, Elalamy I, Chedru F, Ameri A, Samama MM, Bousser MG. Frequency of the 20210 G→A mutation in the 3′-untranslated region of the prothrombin gene in 35 patients with cerebral venous thrombosis. Stroke. 1998;29:319. Abstract.
23. Vandenbroucke JP, Koster T, Briet E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet. 1994;344: 1453-1457. 7
24. Schafer AI. Hypercoagulable states: molecular genetics to clinical practice. Lancet. 1994;344:1739-1742 .
25. Martinelli I, Landi G, Merati G, Cella R, Tosetto A, Mannucci PM. Factor V gene mutation is a risk factor for cerebral venous thrombosis. Thromb Haemostasis. 1996;75:393-394.
26. Zuber M, Toulon P, Marnet L, Mas JL. Factor V Leiden mutation in cerebral venous thrombosis. Stroke. 1996;27:1721-1723.